Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Each year Forbes ranks the world based on a variety of categories ranging from the wealthiest people on the planet to the best colleges America has to offer.